Abstract
Pulmonary arterial hypertension is a major complication of systemic sclerosis. Although oxidative stress, intima hyperplasia and a progressive vessel occlusion appear to be clearly involved, the fine molecular mechanisms underpinning the onset and progression of systemic sclerosis-associated pulmonary arterial hypertension remain largely unknown. Here we shows for the first time that an increase of NADPH-derived reactive oxygen species production induced by sera from systemic sclerosis patients with pulmonary arterial hypertension drives collagen type I promoter activity in primary human pulmonary artery smooth muscle cells, suggesting that antioxidant-based therapies should be considered in the treatment of systemic sclerosis-associated vascular diseases.
| Original language | English |
|---|---|
| Article number | 123 |
| Pages (from-to) | 123 |
| Number of pages | 5 |
| Journal | Orphanet Journal of Rare Diseases |
| Volume | 9 |
| DOIs | |
| Publication status | Published - 1 Aug 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Systemic sclerosis
- Pulmonary arterial hypertension
- Oxidative stress
- Vascular smooth muscle cells
- SYSTEMIC-SCLEROSIS
- DISEASE
Fingerprint
Dive into the research topics of 'Oxidative stress-dependent activation of collagen synthesis is induced in human pulmonary smooth muscle cells by sera from patients with scleroderma-associated pulmonary hypertension'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver